| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | See Remarks | Chief Executive Office
1 company
Anderson Michael S is a Chief Executive Officer at AVADEL PHARMACEUTICALS PLC. Recent SEC Form 4 filings include 9 buys and 1 sell.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2018 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Sell | 16,297 | $4.91 | $79,953.08 | -6.1% | |
| Jun 26, 2018 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 2,500 | $6.04 | $15,100.00 | +1.0% | |
| May 24, 2018 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 3,000 | $6.44 | $19,320.00 | +1.2% | |
| Dec 7, 2017 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 5,000 | $8.86 | $44,295.00 | +2.2% | |
| Sep 12, 2017 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 4,000 | $9.80 | $39,180.00 | +1.8% | |
| May 19, 2017 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 2,500 | $10.00 | $25,000.00 | +1.1% | |
| Nov 21, 2016 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 2,000 | $10.64 | $21,274.00 | +1.0% | |
| Sep 2, 2016 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 2,000 | $14.12 | $28,240.00 | +1.1% | |
| Aug 22, 2016 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 5,000 | $14.30 | $71,478.50 | +2.7% | |
| May 12, 2016 | AVDL Avadel Pharmaceuticals Plc | Chief Executive Officer | Buy | 5,000 | $8.84 | $44,200.00 | +3.9% |